{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:07:56Z","timestamp":1787242076985,"version":"build-2736575974"},"reference-count":82,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The lifetime risk of venous thromboembolism (VTE) is slightly higher in women than in men. There are several issues related to VTE that are unique to women. Combined hormonal contraceptives and pregnancy increase the risk of VTE in women of childbearing age, whereas hormone replacement therapy increases the VTE risk of postmenopausal women. Hereditary thrombophilia and risk factors such as older age, obesity, or smoking contribute to the risk increase. In women diagnosed with acute hormone-related VTE who are treated with oral anticoagulants, adequate contraception is mandatory to avoid unwanted pregnancies. According to current knowledge, hormonal contraception may be continued during anticoagulant therapy but must be switched to an estrogen-free contraception method at least 6 weeks before the termination of anticoagulation. VTE is also a major cause of maternal morbidity and mortality during pregnancy and the postpartum period. Currently, assisted reproduction technologies such as in vitro fertilization are widely used to treat couples affected by infertility. Complications of fertility treatment comprise VTE cases, especially in women with ovarian hyperstimulation syndrome. With this review, we intended to focus on VTE issues in women and summarize current evidence and guideline recommendations.<\/jats:p>","DOI":"10.1055\/a-1919-9558","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:30:12Z","timestamp":1667417412000},"page":"290-299","source":"Crossref","is-referenced-by-count":18,"title":["Venous Thromboembolism Issues in Women"],"prefix":"10.1055","volume":"42","author":[{"given":"Birgit","family":"Linnemann","sequence":"additional","affiliation":[{"name":"Division of Angiology, University Center of Vascular Medicine, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Rott","sequence":"additional","affiliation":[{"name":"Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Zotz","sequence":"additional","affiliation":[{"name":"Centrum f\u00fcr Blutgerinnungsst\u00f6rungen und Transfusionsmedizin, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Haematology and Oncology, Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"04","key":"ref1","first-page":"756","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"A T Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"F Khan","year":"2019","journal-title":"BMJ"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","article-title":"Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death","volume":"37","author":"C AL Arnesen","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"07","key":"ref4","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jth.13712","article-title":"Sex-specific differences in the presenting location of a first venous thromboembolism","volume":"15","author":"L JJ Scheres","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"C G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1963.03060020091034","article-title":"Oral contraception and venous thrombosis","volume":"185","author":"TYLER ET","year":"1963","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.conx.2020.100018","article-title":"Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information","volume":"2","author":"D Khialani","year":"2020","journal-title":"Contracept X"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"S N Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"E Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"G Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2021.09.018","article-title":"Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism","volume":"207","author":"S N Tchaikovski","year":"2021","journal-title":"Thromb Res"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"M Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17\u03b2-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"S Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"J Dinger","year":"2016","journal-title":"Contraception"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"K Gemzell-Danielsson","year":"2022","journal-title":"BJOG"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2021.05.002","article-title":"Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results","volume":"104","author":"M D Creinin","year":"2021","journal-title":"Contraception"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.contraception.2016.08.018","article-title":"Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol","volume":"95","author":"C Kluft","year":"2017","journal-title":"Contraception"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"J Douxfils","year":"2020","journal-title":"Contraception"},{"issue":"03","key":"ref22","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","author":"M de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"A Weill","year":"2016","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"A van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"\u00d8 Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"D D Dore","year":"2010","journal-title":"Contraception"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"O Lidegaard","year":"2012","journal-title":"BMJ"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1097\/MD.0000000000000385","article-title":"Comparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study","volume":"94","author":"B Stocco","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.contraception.2015.09.015","article-title":"Clotting factor changes during the first cycle of oral contraceptive use","volume":"93","author":"C L Westhoff","year":"2016","journal-title":"Contraception"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"N K Tepper","year":"2016","journal-title":"Contraception"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0039-1677806","article-title":"Birth control pills and thrombotic risks: differences of contraception methods with and without estrogen","volume":"39","author":"H Rott","year":"2019","journal-title":"Hamostaseologie"},{"issue":"09","key":"ref33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/a-1471-4408","article-title":"Oral progestins in hormonal contraception: importance and future perspectives of a new progestin only-pill containing 4\u2009mg drospirenone","volume":"81","author":"T R\u00f6mer","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12905-020-01080-9","article-title":"Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4\u2009mg drospirenone alone in a 24\/4 regime","volume":"20","author":"S Palacios","year":"2020","journal-title":"BMC Womens Health"},{"issue":"S 01","key":"ref35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(19)30357-3","article-title":"Optimal management of hormonal contraceptives after an episode of venous thromboembolism","volume":"181","author":"F A Klok","year":"2019","journal-title":"Thromb Res"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"A van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/AOG.0000000000003135","article-title":"Venous thromboembolism among women initiating depot medroxyprogesterone acetate immediately postpartum","volume":"133","author":"N K Tepper","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"E FW van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"94","author":"O Wu","year":"2005","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1055\/s-0039-1677807","article-title":"Common risk factors add to inherited thrombophilia to predict venous thromboembolism risk in families","volume":"3","author":"P Suchon","year":"2019","journal-title":"TH Open"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"F R Rosendaal","year":"1999","journal-title":"Lancet"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1055\/s-0038-1641152","article-title":"Type of combined contraceptives, factor V Leiden mutation and risk of venous thromboembolism","volume":"118","author":"J Hugon-Rodin","year":"2018","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.16666","article-title":"The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk","volume":"191","author":"D Khialani","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1016\/S2352-3026(20)30327-6","article-title":"Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study","volume":"7","author":"J Beyer-Westendorf","year":"2020","journal-title":"Lancet Haematol"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1160\/TH16-11-0838","article-title":"Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment","volume":"117","author":"E H\u00fcttel","year":"2017","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"T Baglin","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref47","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"WHO","year":"2015","edition":"5th ed."},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"I Martinelli","year":"2016","journal-title":"Blood"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11239-017-1584-z","article-title":"Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort","volume":"45","author":"M Villani","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"08","key":"ref50","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jth.14840","article-title":"Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: nationwide cohort study","volume":"18","author":"N Olausson","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","volume":"31","author":"P Humaidan","year":"2016","journal-title":"Hum Reprod"},{"issue":"S 01","key":"ref52","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0049-3848(17)30070-1","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"151","author":"S M Nelson","year":"2017","journal-title":"Thromb Res"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fertnstert.2011.10.038","article-title":"Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles","volume":"97","author":"K Rova","year":"2012","journal-title":"Fertil Steril"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.thromres.2007.05.023","article-title":"The \u201cART\u201d of thromboembolism: a review of assisted reproductive technology and thromboembolic complications","volume":"121","author":"W S Chan","year":"2008","journal-title":"Thromb Res"},{"issue":"09","key":"ref55","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.023","article-title":"Young ischemic stroke in association with ovarian hyperstimulation syndrome","volume":"25","author":"P Sachar","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jcu.22423","article-title":"Internal jugular vein thrombosis with OHSS","volume":"45","author":"S H Lee","year":"2017","journal-title":"J Clin Ultrasound"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"S M Bates","year":"2012","journal-title":"Chest"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"L Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"02","key":"ref59","first-page":"304","article-title":"Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study","volume":"106","author":"R A Virkus","year":"2011","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/a-1132-0750","article-title":"Prevention of venous thromboembolism during pregnancy and the puerperium with a special focus on women with hereditary thrombophilia or prior VTE-position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)","volume":"40","author":"C Hart","year":"2020","journal-title":"Hamostaseologie"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"M Canonico","year":"2008","journal-title":"BMJ"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2018.06.014","article-title":"Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis","volume":"168","author":"D Rovinski","year":"2018","journal-title":"Thromb Res"},{"issue":"13","key":"ref63","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"M Cushman","year":"2004","journal-title":"JAMA"},{"issue":"06","key":"ref64","first-page":"961","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy\u2013results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"E H\u00f8ibraaten","year":"2000","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"e12714","DOI":"10.1002\/rth2.12714","article-title":"Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people","volume":"6","author":"K Glise Sandblad","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jth.12060","article-title":"The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy","volume":"11","author":"R EJ Roach","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: a population-based study","volume":"8","author":"C Renoux","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"M Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jth.12871","article-title":"Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data","volume":"13","author":"M Marcucci","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"j1065","DOI":"10.1136\/bmj.j1065","article-title":"Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study","volume":"356","author":"M A Rodger","year":"2017","journal-title":"BMJ"},{"issue":"06","key":"ref71","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"A Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2004.01050.x","article-title":"High risk of recurrent venous thromboembolism in men","volume":"2","author":"T Baglin","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"25","key":"ref73","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"P A Kyrle","year":"2004","journal-title":"N Engl J Med"},{"issue":"02","key":"ref74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MBC.0b013e3282f54558","article-title":"Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry","volume":"19","author":"B Linnemann","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis","volume":"342","author":"J Douketis","year":"2011","journal-title":"BMJ"},{"issue":"07","key":"ref76","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"C Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"S 01","key":"ref77","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0049-3848(17)30059-2","article-title":"Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use","volume":"151","author":"\u00c1 Blanco-Molina","year":"2017","journal-title":"Thromb Res"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.14516","article-title":"Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink","volume":"177","author":"S Kiconco","year":"2017","journal-title":"Br J Haematol"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1538-7836.2010.03994.x","article-title":"Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event","volume":"8","author":"S C Christiansen","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.contraception.2011.06.008","article-title":"Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives","volume":"84","author":"H Vaillant-Roussel","year":"2011","journal-title":"Contraception"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jth.12528","article-title":"The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study","volume":"12","author":"L Eischer","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref82","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"N van Es","year":"2014","journal-title":"Blood"},{"issue":"09","key":"ref83","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.14549","article-title":"Sex matters: practice 5P's when treating young women with venous thromboembolism","volume":"17","author":"I M Bistervels","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref84","first-page":"885","article-title":"Classic thrombophilic gene variants","volume":"114","author":"P M Mannucci","year":"2015","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10654-013-9825-8","article-title":"Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls","volume":"28","author":"B Simone","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0039-1677840","article-title":"Laboratory diagnostics in thrombophilia","volume":"39","author":"B Linnemann","year":"2019","journal-title":"Hamostaseologie"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1919-9558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T20:04:49Z","timestamp":1678478689000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1919-9558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":82,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,11,2]]},"published-print":{"date-parts":[[2022,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1919-9558","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}